bunazosin has been researched along with Heart Failure in 11 studies
bunazosin: structure
Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Hemodynamic responses to Bunazosin (BZN) in congestive heart failure (CHF) were evaluated for 6 hours (hr) in 30 patients (A, normal cardiac function; B, mild cardiac dysfunction; C, severe cardiac dysfunction)." | 7.68 | Acute hemodynamic effects of bunazosin in congestive heart failure--differing responses according to degree of cardiac dysfunction. ( Kato, M; Kinugawa, T; Kitamura, H; Kotake, H; Mashiba, H; Matsumoto, T; Miyakoda, H; Noguchi, N; Ogino, K; Osaki, S, 1993) |
| "The purpose of this study was to investigate the therapeutic effect of an alpha 1-blocker, bunazosin, using an experimental murine model of congestive heart failure induced by viral myocarditis." | 7.68 | The effect of alpha 1-blocker, bunazosin on a murine model of congestive heart failure induced by viral myocarditis. ( Kawai, C; Matsumori, A; Okada, I; Tominaga, M; Yamada, T, 1992) |
| "To study the effect of bunazosin on exercise capacity in patients with congestive heart failure (NYHA II-III), anaerobic thresholds (AT, VO2, ml/min/kg) were measured before (control) and after initial 1 = 2mg administration of bunazosin (acute phase; N = 14) and after two weeks of bunazosin therapy (3mg/day, 1mg t." | 7.68 | [The acute and chronic effects of bunazosin on exercise capacity estimated by the anaerobic threshold in patients with chronic congestive heart failure]. ( Hosoda, S; Kaneko, N; Kawagoe, Y; Kimata, S; Kimura, H; Konno, K; Miki, N; Nagashima, H; Sumiyoshi, T, 1992) |
| "The acute hemodynamic effect (right atrial pressure, mean pulmonary artery pressure, pulmonary capillary wedge pressure, cardiac index, heart rate, blood pressure) and neurohumoral response (alpha-ANP, plasma renin activity, aldosterone, angiotensin II) of Bunazosin, oral alpha 1 blocker, was investigated in 28 patients with congestive heart failure at rest and immediately after exercise." | 7.67 | [Acute and chronic effects of bunazosin in patients with congestive heart failure]. ( Hasegawa, K; Inoue, S; Kawahara, Y; Nezuo, S; Sawayama, T; Tadaoka, S, 1989) |
| "The hemodynamic parameters (right atrial pressure, mean pulmonary artery pressure, pulmonary capillary wedge pressure, cardiac index, heart rate, blood pressure) and neurohumoral responses (alpha-ANP, plasma renin activity, aldosterone, angiotensin II) of Captopril, oral ACE inhibitor, and Bunazosin, oral alpha 1-blocker, were investigated in 28 patients with congestive heart failure at rest and after exercise." | 7.67 | [The effect of bunazosin vs captopril on hemodynamic and neurohumoral parameters in patients with congestive heart failure]. ( Hasegawa, K; Inoue, S; Kakumae, S; Kawahara, Y; Nakamura, T; Nakao, M; Nezuo, S; Sawayama, T; Tadaoka, S, 1989) |
| " Hemodynamic responses to Bunazosin (BZN) in congestive heart failure (CHF) were evaluated for 6 hours (hr) in 30 patients (A, normal cardiac function; B, mild cardiac dysfunction; C, severe cardiac dysfunction)." | 3.68 | Acute hemodynamic effects of bunazosin in congestive heart failure--differing responses according to degree of cardiac dysfunction. ( Kato, M; Kinugawa, T; Kitamura, H; Kotake, H; Mashiba, H; Matsumoto, T; Miyakoda, H; Noguchi, N; Ogino, K; Osaki, S, 1993) |
| "The purpose of this study was to investigate the therapeutic effect of an alpha 1-blocker, bunazosin, using an experimental murine model of congestive heart failure induced by viral myocarditis." | 3.68 | The effect of alpha 1-blocker, bunazosin on a murine model of congestive heart failure induced by viral myocarditis. ( Kawai, C; Matsumori, A; Okada, I; Tominaga, M; Yamada, T, 1992) |
| "To study the effect of bunazosin on exercise capacity in patients with congestive heart failure (NYHA II-III), anaerobic thresholds (AT, VO2, ml/min/kg) were measured before (control) and after initial 1 = 2mg administration of bunazosin (acute phase; N = 14) and after two weeks of bunazosin therapy (3mg/day, 1mg t." | 3.68 | [The acute and chronic effects of bunazosin on exercise capacity estimated by the anaerobic threshold in patients with chronic congestive heart failure]. ( Hosoda, S; Kaneko, N; Kawagoe, Y; Kimata, S; Kimura, H; Konno, K; Miki, N; Nagashima, H; Sumiyoshi, T, 1992) |
| "The acute hemodynamic effect (right atrial pressure, mean pulmonary artery pressure, pulmonary capillary wedge pressure, cardiac index, heart rate, blood pressure) and neurohumoral response (alpha-ANP, plasma renin activity, aldosterone, angiotensin II) of Bunazosin, oral alpha 1 blocker, was investigated in 28 patients with congestive heart failure at rest and immediately after exercise." | 3.67 | [Acute and chronic effects of bunazosin in patients with congestive heart failure]. ( Hasegawa, K; Inoue, S; Kawahara, Y; Nezuo, S; Sawayama, T; Tadaoka, S, 1989) |
| "The hemodynamic parameters (right atrial pressure, mean pulmonary artery pressure, pulmonary capillary wedge pressure, cardiac index, heart rate, blood pressure) and neurohumoral responses (alpha-ANP, plasma renin activity, aldosterone, angiotensin II) of Captopril, oral ACE inhibitor, and Bunazosin, oral alpha 1-blocker, were investigated in 28 patients with congestive heart failure at rest and after exercise." | 3.67 | [The effect of bunazosin vs captopril on hemodynamic and neurohumoral parameters in patients with congestive heart failure]. ( Hasegawa, K; Inoue, S; Kakumae, S; Kawahara, Y; Nakamura, T; Nakao, M; Nezuo, S; Sawayama, T; Tadaoka, S, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (54.55) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tamagawa, K | 1 |
| Saito, T | 1 |
| Oikawa, Y | 1 |
| Maehara, K | 1 |
| Yaoita, H | 1 |
| Maruyama, Y | 1 |
| Itoh, K | 1 |
| Kohya, T | 1 |
| Nishijima, H | 1 |
| Yasuda, H | 1 |
| Minami, S | 1 |
| Tsujinaga, H | 1 |
| Morimoto, Y | 2 |
| Noda, E | 1 |
| Yamamori, M | 1 |
| Nakai, K | 1 |
| Konishi, T | 2 |
| Kawanami, C | 1 |
| Hamada, M | 1 |
| Nakano, T | 2 |
| Takezawa, H | 2 |
| Ogino, K | 1 |
| Noguchi, N | 1 |
| Osaki, S | 1 |
| Kitamura, H | 1 |
| Matsumoto, T | 1 |
| Kato, M | 1 |
| Kinugawa, T | 1 |
| Miyakoda, H | 1 |
| Kotake, H | 1 |
| Mashiba, H | 1 |
| Takahashi, M | 1 |
| Shichiri, G | 1 |
| Amano, M | 1 |
| Kanamori, T | 1 |
| Kinoshita, M | 1 |
| Yamada, T | 1 |
| Matsumori, A | 1 |
| Okada, I | 1 |
| Tominaga, M | 1 |
| Kawai, C | 1 |
| Kawagoe, Y | 1 |
| Kimura, H | 1 |
| Kaneko, N | 1 |
| Sumiyoshi, T | 1 |
| Nagashima, H | 1 |
| Kimata, S | 1 |
| Hosoda, S | 1 |
| Konno, K | 1 |
| Miki, N | 1 |
| Kawahara, Y | 2 |
| Hasegawa, K | 2 |
| Sawayama, T | 2 |
| Nezuo, S | 2 |
| Inoue, S | 2 |
| Tadaoka, S | 2 |
| Okazaki, Y | 1 |
| Mishima, M | 1 |
| Hirayama, A | 1 |
| Komamura, K | 1 |
| Asada, S | 1 |
| Ohara, T | 1 |
| Lee, JM | 1 |
| Matsumura, Y | 1 |
| Yamamoto, K | 1 |
| Nishida, K | 1 |
| Nakamura, T | 1 |
| Kakumae, S | 1 |
| Nakao, M | 1 |
| Kakuta, Y | 1 |
| Makino, K | 1 |
| Umino, M | 1 |
| Nagano, K | 1 |
| Koyama, T | 1 |
| Kodera, T | 1 |
11 other studies available for bunazosin and Heart Failure
| Article | Year |
|---|---|
Alterations of alpha-adrenergic modulations of coronary microvascular tone in dogs with heart failure.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Blood | 2005 |
[Acute effect of a new alpha 1-receptor blocking drug, E-643, on severe congestive heart failure--pharmacokinetic and hemodynamic studies].
Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Aged; Drug Evaluation; Female; Heart Failure; Hemod | 1983 |
[Acute effects of a new antihypertensive quinazoline derivative, E-643 in severe heart failure--hemodynamics, plasma catecholamine levels and blood gas data (author's transl)].
Topics: Adult; Aged; Catecholamines; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Quinazo | 1981 |
Acute hemodynamic effects of bunazosin in congestive heart failure--differing responses according to degree of cardiac dysfunction.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Blood Pressure; Female; Heart; Heart Failure; Heart Rate; | 1993 |
Increased uncoupling of beta-, beta 1- and beta 2-adrenoceptor to myocardial contraction in failing human myocardium.
Topics: Adult; Aged; Binding, Competitive; Dobutamine; Down-Regulation; Female; Heart Failure; Humans; Iodoc | 1992 |
The effect of alpha 1-blocker, bunazosin on a murine model of congestive heart failure induced by viral myocarditis.
Topics: Adrenergic alpha-Antagonists; Animals; Disease Models, Animal; Encephalomyocarditis virus; Enterovir | 1992 |
[The acute and chronic effects of bunazosin on exercise capacity estimated by the anaerobic threshold in patients with chronic congestive heart failure].
Topics: Adult; Aged; Anaerobic Threshold; Chronic Disease; Exercise Test; Exercise Tolerance; Female; Heart | 1992 |
[Acute and chronic effects of bunazosin in patients with congestive heart failure].
Topics: Adrenergic alpha-Antagonists; Atrial Natriuretic Factor; Chronic Disease; Exercise Test; Female; Hea | 1989 |
[Acute effects of oral bunazosin-hydrochloride in acute heart failure].
Topics: Acute Disease; Administration, Oral; Adrenergic alpha-Antagonists; Aged; Female; Heart Failure; Hemo | 1989 |
[The effect of bunazosin vs captopril on hemodynamic and neurohumoral parameters in patients with congestive heart failure].
Topics: Adrenergic alpha-Antagonists; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; | 1989 |
[Effects of oral bunazosin hydrochloride on hemodynamic and metabolic responses to exercise (ergometer, 25W, 5 min) in patients with severe congestive heart failure].
Topics: Aged; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Metabolism; Middle Aged; Qui | 1987 |